The ability of colchicine to interfere with the activation of the NLRP3 inflammasome, in addition to its effect on microtubule formation and neutrophil-mediated inflammation, points towards the use of colchicine as a potential strategy to target the inflammatory component of atherosclerosis. Here, NLRP3 is linked to atherosclerosis.